Comprehensive adolescent healthcare transition program for congenital adrenal hyperplasia: A quality improvement initiative
- PMID: 39712594
- PMCID: PMC11658564
- DOI: 10.1016/j.hctj.2024.100057
Comprehensive adolescent healthcare transition program for congenital adrenal hyperplasia: A quality improvement initiative
Abstract
Background and significance: Congenital adrenal hyperplasia (CAH) is a genetic condition impairing adrenal steroid production, requiring lifelong steroid replacement, leading to decreased quality of life and a shortened lifespan. Preparing and supporting adolescents with CAH to develop health-related knowledge, skills, and decision-making during the pediatric-to-adult healthcare transition (HCT) is a priority. Many adolescents with CAH do not receive adequate HCT and do not attend follow-up care after transfer to an adult setting. The Comprehensive Adolescent Healthcare Transition (CAH-T) program was developed using CAH care guidelines and the Got Transition Six Core Elements of Healthcare Transition approach.
Purpose: This quality improvement (QI) initiative aimed to evaluate clinicians' utilization and acceptance of the CAH-T program for addressing the HCT needs of adolescents with CAH in a southeastern United States pediatric endocrine clinic.
Intervention: Baseline demographics, the Health Care Transition Feedback Survey for Clinicians, and the Current Assessment of Healthcare Transition Activities were measured using surveys adopted from Got Transition. Clinicians were educated on the CAH-T program and patient education materials. Following implementation, clinicians documented all CAH-T program-recommended interventions provided in the clinic. Surveys were reassessed using repeated measures.
Evaluation: Twenty-nine clinicians participated. Eight separate patients received 53 total CAH-T program-recommended interventions during the three-month observation period. Paired assessment of the Current Assessment of Healthcare Transition Activities scores increased from 15.29 ± 8.32 to 24.00 ± 6.11 (p = 0.018; r = 0.63). The Health Care Transition Feedback Survey for Clinicians mean scores increased from 2.75 ± 0.26 to 3.30 ± 0.43 (p = 0.018; r = 0.59). These measures indicate increased utilization of HCT services and acceptance of HCT value. Clinicians suggested that time limitations, English-only transition education materials, and lack of electronic medical record integration were significant barriers to HCT support.
Implications for practice: A structured HCT program ensures clinicians provide adolescents with CAH support and guideline-based care. The CAH-T program offers an example of developing and implementing an HCT program for adolescents with CAH. Integration in the electronic medical record will ultimately increase program sustainability.
Keywords: Congenital adrenal hyperplasia; Healthcare transition; Quality improvement.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jocelyn Dennis, Leslie Pitts, Leen Matalka, and Lauren Mays reports financial support was provided by Alabama League of Nursing. Leslie Pitts reports a relationship with Eton Pharmaceuticals Inc that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Leslie Pitts, previously employed by Children’s of Alabama Pediatric Endocrinology Clinic. Leen Matalka is currently employed as an attending physician at Children’s of Alabama Pediatric Endocrinology Clinic.
Figures

Similar articles
-
Development of a transition program for emerging adults with type 1 diabetes: A quality improvement initiative.Health Care Transit. 2024 Oct 14;2:100073. doi: 10.1016/j.hctj.2024.100073. eCollection 2024. Health Care Transit. 2024. PMID: 39712597 Free PMC article.
-
Improved medical-alert ID ownership and utilization in youth with congenital adrenal hyperplasia following a parent educational intervention.J Pediatr Endocrinol Metab. 2018 Jan 26;31(2):213-219. doi: 10.1515/jpem-2017-0435. J Pediatr Endocrinol Metab. 2018. PMID: 29315077 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care.Korean J Pediatr. 2017 Feb;60(2):31-37. doi: 10.3345/kjp.2017.60.2.31. Epub 2017 Feb 27. Korean J Pediatr. 2017. PMID: 28289431 Free PMC article. Review.
-
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.Cochrane Database Syst Rev. 2020 Mar 19;3(3):CD012517. doi: 10.1002/14651858.CD012517.pub2. Cochrane Database Syst Rev. 2020. PMID: 32190901 Free PMC article.
References
LinkOut - more resources
Full Text Sources